LSV Asset Management Has $8.42 Million Stock Position in Tenet Healthcare Co. (NYSE:THC)

LSV Asset Management increased its holdings in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 43.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,400 shares of the company's stock after purchasing an additional 33,659 shares during the period. LSV Asset Management owned approximately 0.11% of Tenet Healthcare worth $8,418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. M&T Bank Corp increased its stake in shares of Tenet Healthcare by 10.8% during the fourth quarter. M&T Bank Corp now owns 4,521 shares of the company's stock worth $342,000 after purchasing an additional 439 shares in the last quarter. Levin Capital Strategies L.P. acquired a new stake in shares of Tenet Healthcare in the fourth quarter worth approximately $1,684,000. Sivik Global Healthcare LLC raised its stake in Tenet Healthcare by 3.6% in the 4th quarter. Sivik Global Healthcare LLC now owns 145,000 shares of the company's stock valued at $10,958,000 after purchasing an additional 5,000 shares during the last quarter. SummerHaven Investment Management LLC boosted its stake in Tenet Healthcare by 1.7% during the 4th quarter. SummerHaven Investment Management LLC now owns 8,685 shares of the company's stock worth $656,000 after purchasing an additional 145 shares during the last quarter. Finally, Retirement Systems of Alabama raised its holdings in Tenet Healthcare by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 127,189 shares of the company's stock valued at $9,612,000 after acquiring an additional 412 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Down 1.0 %

Shares of Tenet Healthcare stock traded down $1.21 during trading hours on Wednesday, hitting $122.86. The company had a trading volume of 1,541,032 shares, compared to its average volume of 1,216,267. The company has a market cap of $12.00 billion, a P/E ratio of 4.82, a price-to-earnings-growth ratio of 1.22 and a beta of 2.09. The company's 50-day moving average is $101.66 and its two-hundred day moving average is $83.73. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.44 and a quick ratio of 1.37. Tenet Healthcare Co. has a twelve month low of $51.04 and a twelve month high of $124.92.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, April 30th. The company reported $3.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $1.77. Tenet Healthcare had a net margin of 12.53% and a return on equity of 26.76%. The company had revenue of $5.37 billion during the quarter, compared to analysts' expectations of $5.15 billion. During the same quarter in the previous year, the business posted $1.42 earnings per share. The firm's quarterly revenue was up 6.9% compared to the same quarter last year. Analysts anticipate that Tenet Healthcare Co. will post 8.73 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on THC shares. StockNews.com raised Tenet Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Thursday, May 2nd. Mizuho restated a "buy" rating and issued a $130.00 target price (up previously from $118.00) on shares of Tenet Healthcare in a research report on Wednesday, May 1st. Stephens increased their price target on Tenet Healthcare from $95.00 to $122.00 and gave the stock an "equal weight" rating in a report on Wednesday, May 1st. Wolfe Research upgraded shares of Tenet Healthcare from a "peer perform" rating to an "outperform" rating and set a $122.00 price objective on the stock in a report on Wednesday, March 27th. Finally, UBS Group lifted their price target on shares of Tenet Healthcare from $137.00 to $150.00 and gave the company a "buy" rating in a research report on Wednesday, May 1st. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $113.19.

Insider Activity

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 17,000 shares of the business's stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the completion of the sale, the executive vice president now owns 8,148 shares of the company's stock, valued at $772,756.32. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Tenet Healthcare news, Director Richard J. Mark sold 14,000 shares of the stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $98.98, for a total value of $1,385,720.00. Following the completion of the sale, the director now owns 33,303 shares of the company's stock, valued at $3,296,330.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas W. Arnst sold 17,000 shares of the business's stock in a transaction on Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the transaction, the executive vice president now directly owns 8,148 shares in the company, valued at $772,756.32. The disclosure for this sale can be found here. Insiders sold a total of 59,416 shares of company stock valued at $5,890,793 in the last 90 days. 0.93% of the stock is currently owned by insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.